📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease. (2016)

First Author: Canavan JB

Attributed to: T-bet as a master regulator of mucosal immunity and inflammatory bowel disease. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/gutjnl-2014-306919

PubMed Identifier: 25715355

Publication URI: http://europepmc.org/abstract/MED/25715355

Type: Journal Article/Review

Volume: 65

Parent Publication: Gut

Issue: 4

ISSN: 0017-5749